| Volume I. introduction to DUNE B Abi, R Acciarri, MA Acero, G Adamov, D Adams, M Adinolfi, Z Ahmad, ... Journal of instrumentation 15 (08), T08008, 2020 | 692* | 2020 |
| Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan RM Zuniga, R Torcuator, R Jain, J Anderson, T Doyle, S Ellika, L Schultz, ... Journal of neuro-oncology 91 (3), 329-336, 2009 | 340 | 2009 |
| Chimeric antigen receptor-engineered human gamma delta T cells: enhanced cytotoxicity with retention of cross presentation A Capsomidis, G Benthall, HH Van Acker, J Fisher, AM Kramer, Z Abeln, ... Molecular Therapy 26 (2), 354-365, 2018 | 291 | 2018 |
| Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA A Godfrey, J Anderson, A Papanastasiou, Y Takeuchi, C Boshoff Blood 105 (6), 2510-2518, 2005 | 223 | 2005 |
| γδ T cells for cancer immunotherapy: a systematic review of clinical trials JPH Fisher, J Heuijerjans, M Yan, K Gustafsson, J Anderson Oncoimmunology 3 (1), e27572, 2014 | 221 | 2014 |
| DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner GO Gillard, B Collette, J Anderson, J Chao, RH Scannevin, DJ Huss, ... Journal of neuroimmunology 283, 74-85, 2015 | 219 | 2015 |
| Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma K Straathof, B Flutter, R Wallace, N Jain, T Loka, S Depani, G Wright, ... Science translational medicine 12 (571), eabd6169, 2020 | 213 | 2020 |
| Genes, chromosomes, and rhabdomyosarcoma J Anderson, A Gordon, K Pritchard‐Jones, J Shipley Genes, Chromosomes and Cancer 26 (4), 275-285, 1999 | 201 | 1999 |
| Osteogenesis imperfecta is linked to both type I collagen structural genes B Sykes, P Wordsworth, D Ogilvie, J Anderson, N Jones The Lancet 328 (8498), 69-72, 1986 | 197 | 1986 |
| Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization S Weber-Hall, J Anderson, A McManus, S Abe, T Nojima, R Pinkerton, ... Cancer research 56 (14), 3220-3224, 1996 | 190 | 1996 |
| Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells N Himoudi, DA Morgenstern, M Yan, B Vernay, L Saraiva, Y Wu, ... The Journal of Immunology 188 (4), 1708-1716, 2012 | 182 | 2012 |
| Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell G Kildisiute, WM Kholosy, MD Young, K Roberts, R Elmentaite, ... Science advances 7 (6), eabd3311, 2021 | 173 | 2021 |
| New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK G Barone, J Anderson, ADJ Pearson, K Petrie, L Chesler Clinical Cancer Research 19 (21), 5814-5821, 2013 | 171 | 2013 |
| Embryonal precursors of Wilms tumor THH Coorens, TD Treger, R Al-Saadi, L Moore, MGB Tran, TJ Mitchell, ... Science 366 (6470), 1247-1251, 2019 | 158 | 2019 |
| Relationship Between MYCN Copy Number and Expression in Rhabdomyosarcomas and Correlation With Adverse Prognosis in the Alveolar Subtype D Williamson, YJ Lu, T Gordon, R Sciot, A Kelsey, C Fisher, C Poremba, ... Journal of Clinical Oncology 23 (4), 880-888, 2005 | 158 | 2005 |
| A molecular map of mesenchymal tumors SR Henderson, D Guiliano, N Presneau, S McLean, R Frow, S Vujovic, ... Genome biology 6 (9), R76, 2005 | 152 | 2005 |
| Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity Y Grabovska, A Mackay, P O’Hare, S Crosier, M Finetti, EC Schwalbe, ... Nature communications 11 (1), 4324, 2020 | 145 | 2020 |
| Identification of new Wilms tumour predisposition genes: an exome sequencing study S Mahamdallie, S Yost, E Poyastro-Pearson, E Holt, A Zachariou, S Seal, ... The Lancet Child & Adolescent Health 3 (5), 322-331, 2019 | 141 | 2019 |
| Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity F Mussai, S Egan, S Hunter, H Webber, J Fisher, R Wheat, C McConville, ... Cancer research 75 (15), 3043-3053, 2015 | 133 | 2015 |
| Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells JPH Fisher, M Yan, J Heuijerjans, L Carter, A Abolhassani, J Frosch, ... Clinical Cancer Research 20 (22), 5720-5732, 2014 | 128 | 2014 |
